Folitrax LP Gel (Methotrexate (1% w/w))

Folitrax LP Gel is a topical medication indicated for the management of severe psoriasis, particularly in cases where alternative treatments have not yielded favorable results. This formulation works by targeting and reducing the rapid proliferation of skin cells associated with this chronic condition. In addition to psoriasis, it may also be utilized to address other skin disorders as evaluated and prescribed by a healthcare professional. It is important to apply the gel solely on the skin’s surface, adhering strictly to the guidance provided by your physician regarding dosage and frequency of application. Patients are advised to continue using this treatment as directed by their healthcare provider and not to discontinue its use without prior consultation. While Folitrax LP Gel is generally regarded as safe and well-tolerated, any unusual reactions or symptoms should be promptly reported to a healthcare provider for further advice. Before starting treatment with Folitrax LP Gel, it is essential to inform your doctor about any existing liver or kidney issues, as well as any ongoing medications for infections or other conditions. Additionally, the use of this medication is contraindicated during pregnancy and lactation due to potential risks to the fetus or nursing child. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.